NOVATO, Calif.--(BUSINESS WIRE)--Aug. 21, 2006--Diamics, Inc., a San Francisco Bay-area, medical device and diagnostics company, today announced it has submitted a 510(k) premarket notification application to the FDA for its proprietary CerCol cervical collection device. The CerCol device is designed to improve screening for cervical cancer and greater comfort to the patient.
